More reports from the UK on the use of BTM in non-burn wound reconstruction.
Two abstracts from the University Hospitals Coventry & Warwickshire have been published in the Annals of the Royal College of Surgeons of England, March 2024.
Both abstracts report on a retrospective observational study of 37 patients who underwent non-burn wound reconstruction using Novosorb BTM between January 2020 and September 2022.
Conclusions This study underscores Novosorb as a valuable addition to non-burn wound management, even in challenging clinical scenarios. Vigilant clinical monitoring and meticulous wound bed optimisation are essential, especially for elderly, diabetic, or co-morbid patients with chronic or malignant wounds. Despite potential complications, Novosorb consistently proves to be a robust and reliable choice for enhancing patient outcomes in non-burn wound reconstruction.
- Wound aetiologies included: acute trauma (51.4%), chronic wounds (24.3%), infections with tissue loss (16.2%), and soft tissue or skin cancer (8.1%).TBSA was 1%, most frequent wound site was lower limb (56.8%), whereas wound bed was muscle/fascia (48.6%).
- There was a 74.3% success rate in achieving Novosorb integration.
- Notably, all patients achieved complete wound healing. Median time to complete wound healing was 101 days.
- Patients aged 65 and above experienced higher complication rates (72.7%), while younger patients exhibited significantly lower complication rates (34.6%).
- Complications occurred in 45.9% of patients: highest rates seen in cases involving malignancy (66.7%) and chronic wounds (55.6%).
- Factors such as wound bed characteristics, and diabetic status showed no substantial influence on either integration or complication rates.
- Age, gender and smoking history were not significantly associated with BTM loss.
![]()
- Forums
- ASX - By Stock
- PNV
- The Clinicians Speak
The Clinicians Speak, page-844
-
- There are more pages in this discussion • 206 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.33 |
Change
0.030(1.30%) |
Mkt cap ! $1.609B |
Open | High | Low | Value | Volume |
$2.29 | $2.34 | $2.27 | $2.949M | 1.276M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 19139 | $2.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.34 | 14111 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 19139 | 2.310 |
4 | 13267 | 2.300 |
4 | 17455 | 2.290 |
1 | 2062 | 2.280 |
2 | 6562 | 2.270 |
Price($) | Vol. | No. |
---|---|---|
2.340 | 14111 | 3 |
2.350 | 9293 | 2 |
2.360 | 9455 | 2 |
2.370 | 5198 | 2 |
2.380 | 12335 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |